Fasenra approved in China for the treatment of severe eosinophilic asthma
Approval based on MIRACLE Phase III trial demonstrating a significant and clinically meaningful reduction in asthma exacerbations and improvement in asthma symptom control
Approval based on MIRACLE Phase III trial demonstrating a significant and clinically meaningful reduction in asthma exacerbations and improvement in asthma symptom control
He recently served as Senior Vice President of the API business at Shilpa Pharma Life Sciences for over 3 years
This project is supported by the Irish Government through IDA Ireland
Experienced commercial leader takes helm to expand cardiovascular diagnostic company globally and commercialize company’s flagship plaque analysis software
The expiry date of almost all strips is rubber stamped vanish in a matter of 3 to 4 months, making the remaining tablets waste for subsequent use before expire date
Abdel has held leadership positions at Bayer, Merck, Catalent, Lonza, and KBI Biopharma,
Co-founder and previous CEO Lowry Curley becomes Chief Scientific Officer
Largest investment in active pharmaceutical ingredient manufacturing of synthetic medicines in U.S. history
The new 10-year contract will focus on strengthening the partnership for continued transformative innovation for patients
Subscribe To Our Newsletter & Stay Updated